
The Future of
Precision Health
Experience the world’s first AI-native multi-sensor
platform — powered by our real-time Digital Twin Engine.


Our Vision is Simple
Detect early. Escalate intelligently. Document automatically.
KardioGenics is on a mission to close the gaps created by fragmented, episodic healthcare. We envision a world where care is continuous, predictive, and intelligent — powered by real-time physiological data and adaptive AI.
By replacing disconnected tools with a unified multi-sensor platform and a real-time Digital Twin Engine, we’re making hospital-grade monitoring possible anywhere care happens , from bedside to battlefield, from city hospitals to space medicine.


OUR PRODUCT
Driving Innovation in Healthcare
KardioAccess Device
The world’s first AI-native,
multi-sensor diagnostic platform.
KardioAccess consolidates ECG, PPG, cuffless BP, SpO₂, temperature, respiration, and motion sensing into a single synchronized, FDA-bound device — delivering hospital-grade intelligence anywhere care happens.
Capabilities
-
Compact, ruggedized, and field-ready design.
-
Continuous multimodal physiological monitoring.
-
Real-time, time-synced data streaming to the cloud.




AI-Powered Digital Twin Engine
Predictive intelligence that sees ahead.
The KardioGenics Digital Twin Engine continuously models patient physiology to enable early detection, triage support, and adaptive treatment guidance—turning raw data into predictive clinical foresight.
Capabilities
-
Real-time, contextual alerts
-
Automated Documentation
-
Tiered Escalations into clinical workflows.
Advanced Virtual Hospital Platform
Bringing hospital-grade insight anywhere.
The KardioGenics Virtual Platform seamlessly aggregates and streams physiological data from KardioAccess devices into EHRs, enabling providers across hospitals, home care, and defense medicine to access real-time patient status.
Capabilities
-
Real-time dashboards and remote care monitoring.
-
Seamless EMR integration and automated documentation.
-
Scalable architecture for telehealth and clinical trials.


we preserve hospital-grade continuity anywhere care happens.
Because every second matters — and no patient should be lost to delayed care.
COMPANY
Volaso in Numbers
247
Employees
5
Core Teams
326
Partners Worldwide
$200m
Capital

COLLABORATION
Our Industry Partners














